Proteasome Inhibitors Market Size to Grow by USD 2.20 billion | 43% of Market Growth to Originate from North America | Technavio

Top Key players in Proteasome Inhibitors Market

• AbbVie Inc.
• Accuitis Inc.
• Amgen Inc.
• Bristol Myers Squibb Co.
• Cantex Pharmaceuticals Inc.
• Fresenius SE and Co. KGaA
• Johnson and Johnson
• Takeda Pharmaceutical Co. Ltd.
• TG Therapeutics Inc.

Find more information about key vendors and their offerings. Download an Exclusive Sample Report

The huge unmet need is one of the key drivers of the market. For instance, the market has very few approved therapies for the treatment of pancreatic cancer. Various vendors are developing proteasome inhibitors in the late stages of clinical trials for multiple myeloma and two drugs for pancreatic cancer. Thus, the unmet need is expected to attract various large and mid-sized pharmaceutical vendors to conduct studies and launch products.

The threat from biologics is challenging the growth of the market. Various vendors are developing drugs for the treatment of solid tumors such as pancreatic cancer and malignant melanoma. For instance, AbbVie is developing KYPROLIS, which is in the phase II stage of clinical trials for the treatment of prostate cancer and renal cell carcinoma. Similarly, Takeda is developing VELCADE, which is in the Phase II stage of clinical trials for the treatment of glioma. Vendors face a threat from substitutes, with the increasing number of highly effective biologics such as PD-1 and PD-L1 inhibitors.

• Proteasome Inhibitors Market Split by Product
• VELCADE: This segment will have the highest market share growth during the forecast period. VELCADE inhibits the proteasome enzyme complex within the cell, which is a part of the cellular machinery. It also plays a major role in the regulation of cell division and cell survival. Such factors of VELCADE will drive the growth of the proteasome inhibitors market during the forecast period.
• KYPROLIS
• NINLARO
• Others
• Proteasome Inhibitors Market Split by Geography
• North America: This region will have the highest market share growth during the forecast period. This growth is attributed to factors such as advanced healthcare infrastructure. However, market growth in this region will be slower than the growth of the market in other regions. The US and Canada are the key countries for the proteasome inhibitors market in North America.
• Europe
• Asia
• Rest of World (ROW)

• What was the size of the global proteasome inhibitors industry by value in 2020?
• What will be the size of the global proteasome inhibitors industry in 2026?
• What factors are affecting the strength of competition in the global proteasome inhibitors industry?
• How has the industry performed over the last five years?
• What are the main segments that make up the global proteasome inhibitors market?

Subscribe to our "Basic Plan" billed annually at USD 5000. Get lifetime access to our Technavio Insights

• Identify factors affecting growth prospects across markets.
• Track competitor gains and losses in market share.
• Get a Holistic View of the Market

BRAF Kinase Inhibitors Market by Product and Geography - Forecast and Analysis 2022-2026

Anaplastic Thyroid Cancer Drugs Market by Product and Geography - Forecast and Analysis 2022-2026

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

• 5.1 Market segments
• Exhibit 24: Chart on Product - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Product - Market share 2021-2026 (%)

• 5.2 Comparison by Product
• Exhibit 26: Chart on Comparison by Product
• Exhibit 27: Data Table on Comparison by Product

• 5.3 VELCADE - Market size and forecast 2021-2026
• Exhibit 28: Chart on VELCADE - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on VELCADE - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on VELCADE - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on VELCADE - Year-over-year growth 2021-2026 (%)

• 5.4 KYPROLIS - Market size and forecast 2021-2026
• Exhibit 32: Chart on KYPROLIS - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on KYPROLIS - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on KYPROLIS - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on KYPROLIS - Year-over-year growth 2021-2026 (%)

• 5.5 NINLARO - Market size and forecast 2021-2026
• Exhibit 36: Chart on NINLARO - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on NINLARO - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on NINLARO - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on NINLARO - Year-over-year growth 2021-2026 (%)

• 5.6 Others - Market size and forecast 2021-2026
• Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)

• 5.7 Market opportunity by Product
• Exhibit 44: Market opportunity by Product ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 46: Chart on Market share by geography 2021-2026 (%)
• Exhibit 47: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison
• Exhibit 48: Chart on Geographic comparison
• Exhibit 49: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026
• Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 UK - Market size and forecast 2021-2026
• Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)

• 7.9 Germany - Market size and forecast 2021-2026
• Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 7.10 Canada - Market size and forecast 2021-2026
• Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)

• 7.11 France - Market size and forecast 2021-2026
• Exhibit 82: Chart on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 83: Data Table on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 84: Chart on France - Year-over-year growth 2021-2026 (%)
• Exhibit 85: Data Table on France - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography
• Exhibit 86: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges
• Exhibit 87: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape
• Exhibit 88: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption
• Exhibit 89: Overview on factors of disruption

• 9.4 Industry risks
• Exhibit 90: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 91: Vendors covered

• 10.2 Market positioning of vendors
• Exhibit 92: Matrix on vendor position and classification

• 10.3 AbbVie Inc.
• Exhibit 93: AbbVie Inc. - Overview
• Exhibit 94: AbbVie Inc. - Product / Service
• Exhibit 95: AbbVie Inc. - Key offerings

• 10.4 Accuitis Inc.
• Exhibit 96: Accuitis Inc. - Overview
• Exhibit 97: Accuitis Inc. - Product / Service
• Exhibit 98: Accuitis Inc. - Key offerings

• 10.5 Amgen Inc.
• Exhibit 99: Amgen Inc. - Overview
• Exhibit 100: Amgen Inc. - Product / Service
• Exhibit 101: Amgen Inc. - Key offerings

• 10.6 Bristol Myers Squibb Co.
• Exhibit 102: Bristol Myers Squibb Co. - Overview
• Exhibit 103: Bristol Myers Squibb Co. - Product / Service
• Exhibit 104: Bristol Myers Squibb Co. - Key offerings

• 10.7 Cantex Pharmaceuticals Inc.
• Exhibit 105: Cantex Pharmaceuticals Inc. - Overview
• Exhibit 106: Cantex Pharmaceuticals Inc. - Product / Service
• Exhibit 107: Cantex Pharmaceuticals Inc. - Key news
• Exhibit 108: Cantex Pharmaceuticals Inc. - Key offerings

• 10.8 Fresenius SE and Co. KGaA
• Exhibit 109: Fresenius SE and Co. KGaA - Overview
• Exhibit 110: Fresenius SE and Co. KGaA - Business segments
• Exhibit 111: Fresenius SE and Co. KGaA - Key news
• Exhibit 112: Fresenius SE and Co. KGaA - Key offerings
• Exhibit 113: Fresenius SE and Co. KGaA - Segment focus

• 10.9 Johnson and Johnson
• Exhibit 114: Johnson and Johnson - Overview
• Exhibit 115: Johnson and Johnson - Business segments
• Exhibit 116: Johnson and Johnson - Key news
• Exhibit 117: Johnson and Johnson - Key offerings
• Exhibit 118: Johnson and Johnson - Segment focus

• 10.10 Takeda Pharmaceutical Co. Ltd.
• Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 121: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 122: Takeda Pharmaceutical Co. Ltd. - Key offerings

• 10.11 TG Therapeutics Inc.
• Exhibit 123: TG Therapeutics Inc. - Overview
• Exhibit 124: TG Therapeutics Inc. - Product / Service
• Exhibit 125: TG Therapeutics Inc. - Key offerings

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist
• Exhibit 126: Inclusions checklist
• Exhibit 127: Exclusions checklist

• 11.3 Currency conversion rates for US$
• Exhibit 128: Currency conversion rates for US$

• 11.4 Research methodology
• Exhibit 129: Research methodology
• Exhibit 130: Validation techniques employed for market sizing
• Exhibit 131: Information sources

• 11.5 List of abbreviations
• Exhibit 132: List of abbreviations

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact Us:
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio